ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Hofseth Biocare Asa

Hofseth Biocare Asa (0Q6H)

2.00
0.00
(0.00%)
Closed 06 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.00
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
2.00 52 Week Range 2.00
Market Cap
Previous Close
2.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,664
Shares Outstanding
395,081,000
Dividend Yield
-
PE Ratio
-7.41
Earnings Per Share (EPS)
-0.27
Revenue
218.51M
Net Profit
-106.68M

About Hofseth Biocare Asa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Alesund, Nor
Founded
-
Hofseth Biocare Asa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Q6H. The last closing price for Hofseth Biocare Asa was kr2. Over the last year, Hofseth Biocare Asa shares have traded in a share price range of kr 2.00 to kr 2.00.

Hofseth Biocare Asa currently has 395,081,000 shares in issue. The market capitalisation of Hofseth Biocare Asa is kr790.16 million. Hofseth Biocare Asa has a price to earnings ratio (PE ratio) of -7.41.

0Q6H Latest News

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today purchased 700,000 shares in HBC...

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity Hofseth BioCare ASA ("HBC" or the "Company", and together with its consolidated subsidiaries...

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating...

Hofseth Biocare ASA: CFO RESIGNATION

Hofseth Biocare ASA: CFO RESIGNATION Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company...

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT Ålesund, Norway, 8 October 2024. HBC Immunology (HBCI) is pleased to announce the successful...

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year...

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY Ålesund, Norway, 14 August, 2024 - Hofseth BioCare (HBC), a leader in...

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine...

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY Hofseth BioCare ASA (HBC) is delighted to announce the appointment of Lithy One-Health Group Technology Co. Ltd...

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10022200DE
4002226452DE
120022226642DE
260022211802DE
520022211802DE
156002226592DE
2600022226352DE

0Q6H - Frequently Asked Questions (FAQ)

What is the current Hofseth Biocare Asa share price?
The current share price of Hofseth Biocare Asa is kr 2.00
How many Hofseth Biocare Asa shares are in issue?
Hofseth Biocare Asa has 395,081,000 shares in issue
What is the market cap of Hofseth Biocare Asa?
The market capitalisation of Hofseth Biocare Asa is NOK 790.16M
What is the 1 year trading range for Hofseth Biocare Asa share price?
Hofseth Biocare Asa has traded in the range of kr 2.00 to kr 2.00 during the past year
What is the PE ratio of Hofseth Biocare Asa?
The price to earnings ratio of Hofseth Biocare Asa is -7.41
What is the cash to sales ratio of Hofseth Biocare Asa?
The cash to sales ratio of Hofseth Biocare Asa is 3.62
What is the reporting currency for Hofseth Biocare Asa?
Hofseth Biocare Asa reports financial results in NOK
What is the latest annual turnover for Hofseth Biocare Asa?
The latest annual turnover of Hofseth Biocare Asa is NOK 218.51M
What is the latest annual profit for Hofseth Biocare Asa?
The latest annual profit of Hofseth Biocare Asa is NOK -106.68M
What is the registered address of Hofseth Biocare Asa?
The registered address for Hofseth Biocare Asa is HAVNEGATA 11, ALESUND, 6005
What is the Hofseth Biocare Asa website address?
The website address for Hofseth Biocare Asa is www.hofsethbiocare.com
Which industry sector does Hofseth Biocare Asa operate in?
Hofseth Biocare Asa operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Viking61 Viking61 5 minutes ago
Rick , do you have a kick starter on that whale horn??
FNMA
MartinLutherKing MartinLutherKing 5 minutes ago
Will they get an FDA fast track status for terminally ill cancer patients
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors
barnyarddog barnyarddog 5 minutes ago
About us


GCT Semiconductor is a leading fabless designer and supplier of advanced 4G LTE semiconductor solutions. GCT’s market-proven LTE solutions enable fast and reliable LTE connectivity to wireless devices such as smartphones, tablets, hotspots, USB dongles,
GCT
tdbowieknife tdbowieknife 6 minutes ago
I just checked Sedar and still nothing filed. I know they could if they tried as there have been 6 other disclosure docs filed Today. Some of them PR's a few Material change.

.
TWOH
kid70 kid70 6 minutes ago
I wish JB would actually give you something new to report on.  You are reporting on old and false news.   Kevin is working for another company and Kevin has sold the building 
UBQU
Lime Time Lime Time 7 minutes ago
Very nice. Gonna be a good one VGTL
VGTL
ron_66271 ron_66271 7 minutes ago
Marty Only has Two Weeks to Complete His Tasks.

Too control the narrative.
You do the math?!

Remember that JPM and the FDIC Lost in DC Court.
DOCUMENTED!



Ron
JPM
trunkmonk trunkmonk 7 minutes ago
Light took a guess where Carney was by a pic he posted, CarneyClown is on Jekyll island, his clue was a pic of drift wood on the beach, it was as cryptic and lacking in background, its something only Carney could think we all have time to figure out 10,000 places on earth just to see where he is. wh
FNMA
Lifetime Lifetime 8 minutes ago
You know that is not based in reality. Shameful.
jour_trader jour_trader 8 minutes ago
There is one patent (434 patent) that Purdue claimed against Accord that I don't see a ruling on. This is against Elite too. 

4 of these patents have been filed against Abai and KVK-Tech. Another filed against Amneal and Kashiv. 

There are 2 patents where Elite stands a
ELTP
barnyarddog barnyarddog 8 minutes ago
GCTS - Semiconductor signs MOU with Samsung to accelerate the development of 4G/5G chipsets and modules

SAN JOSE, CA – August 13, 2024
https://www.gctsemi.com/samsung-pr-august-13-2024

July 23, 2024 GCT Semiconductor and Ligado Networks Announce Commercial Avai
GCT GCTS
gfp927z gfp927z 8 minutes ago
>>> Moody’s Acquires Numerated Growth Technologies, Expanding Lending Technology Solutions


Business Wire

November 21, 2024


https://finance.yahoo.com/news/moody-acquires-numerated-growth-technologies-130000091.html


NE
MCO
juicyjuice10002 juicyjuice10002 9 minutes ago
Let it trade on a real exchange so all the players sitting cn sideline can come and decide the price. There will be analysts from all over on this case. My invetment advisor claims the price will be over 90.
https://sinvestsllc.com/fannie-mae-fnma-price-target-90/
FNMA
3331 3331 9 minutes ago
Another GetSeriousOK gem!
Tuesday, 12/12/2023 7:42:35 PM
Post #324816

There's nothing so critically wrong with BIEL that it can't be fixed. This company isn't screwing shareholders the way ENDV is screwing shareholders, for example.
ENDV
KILLAZILLA KILLAZILLA 9 minutes ago
Hallelujah!!!!
MNMD
MartinLutherKing MartinLutherKing 10 minutes ago
Is NIH a scam like the fda
https://synapse.patsnap.com/article/transcode-therapeutics-receives-2m-nih-grant-for-lead-candidate-clinical-evaluation
jobynimble jobynimble 10 minutes ago
https://x.com/krtlbiotech/status/1876063562759868634?s=61&t=yVFUOJsDIX47DnFKN2pKtQ

“Attention $KRTL shareholders: Our website, krtlbiotech.com, will be going live soon, accompanied by a scheduled press release detailing its features and functions.”
KRTL
tredenwater2 tredenwater2 11 minutes ago
Roger that loud n clear!
MUX
newmedman newmedman 11 minutes ago
cdn.bsky.app/img/feed_thumbnail/plain/did:plc:mzvcmrbi3poceuzt66ujpw46/bafkreidxznbasw7r6ukdetmm4pa2sc3uvljsfcof272uebdt7dbjmtzm3a@jpeg
trader59 trader59 12 minutes ago
He stops in often enough to keep his moderator status and uses re-hashed previously debunked garbage from the fairy tale he and the others you call the "good guys" used to flip the stock for profit. That's it.
You've declared it to be over a few times only to return to another sliver of the
joyceschoice joyceschoice 12 minutes ago
Yes let's make this a Lehman political board to solve all of the problems that currently are at issue. Economic inequality and political pandering, free speech, women's right to health care, school shootings and gun control for the children women bear, mass shootings and gun control for the humans
LEHNQ
tdbowieknife tdbowieknife 13 minutes ago
Cause that is not what is happening... TWOH needs to PR the Change of control and file the docs and PR on Sedar. They screwed it up badly by filing that 8-k and not following Canadian disclosure at the same time.... Now they need to fix it. They for sure will NOT lift the halt until the disclosu
TWOH
Poo28 Poo28 13 minutes ago
LTI’s do loans—cashflow financing. No equity. No increase in OS since June 2023. Maybe your opinion is because your short selling pals are telling you what to say?

Stop making it up as you go along. False, false and false.?
DBMM

Your Recent History

Delayed Upgrade Clock